β2 Adrenoceptor Functional Gene Variants, Obesity, and Blood Pressure Level Interactions in the General Population

Hypertension

Volumn 42, Issue 4, 2003, Pages 685-692

  Pereira, Alexandre C ^a   Floriano, Marcilene S ^a   Mota, Glória F A ^a   Cunha, Roberto S ^a   Herkenhoff, Fernando L ^a   Mill, José G ^a   Krieger, José E ^a  

^a FEDERAL UNIVERSITY OF ESPÍRITO SANTO   (Brazil)

Author keywords

Adrenergic beta; Genetics; Hypertension; Obesity; Polymorphism; Receptors

Indexed keywords

ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; STIMULATORY GUANINE NUCLEOTIDE BINDING PROTEIN; TRIACYLGLYCEROL;

ADULT; AGED; ALLELE; BLOOD PRESSURE MEASUREMENT; BODY MASS; CONFERENCE PAPER; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENETIC HETEROGENEITY; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC VARIABILITY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; OBESITY; POPULATION RESEARCH; PRIORITY JOURNAL; RECEPTOR GENE; SYSTOLIC BLOOD PRESSURE; URBAN POPULATION; ARTICLE; BLOOD PRESSURE; CROSS-SECTIONAL STUDY; DEMOGRAPHY; GENE FREQUENCY; GENETICS; MIDDLE AGED; PHENOTYPE;

ADULT; AGED; BLOOD PRESSURE; CROSS-SECTIONAL STUDIES; DEMOGRAPHY; FEMALE; GENE FREQUENCY; HUMANS; MALE; MIDDLE AGED; OBESITY; PHENOTYPE; POLYMORPHISM, GENETIC; RECEPTORS, ADRENERGIC, BETA-2;

EID: 0141928183     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/01.HYP.0000085648.65419.17     Document Type: Article

References (21)

1. Lifton RP, Gharavi AG, Geller DS. Molecular mechanisms of human hypertension. Cell. 2001; 104: 545-556.
2. Clement K, Ferre P. Genetics and the pathophysiology of obesity. Pediatr Res. 2003; 53: 721-725.
3. Hamann A, Sharma AM. Genetics of obesity and obesity-related hypertension. Semin Nephrol. 2002; 22: 100-104.
4. Fagius J. Sympathetic nerve activity in metabolic control: some basic concepts. Acta Physiol Scand. 2003; 177: 337-433.
5. Guimaraes S, Moura D. Vascular adrenoceptors: an update. Pharmacol Rev. 2001; 53: 319-356.
6. van Baak MA. The peripheral sympathetic nervous system in human obesity. Obes Ver. 2001; 2: 3-14.
7. Tomaszewski M, Brain NJ, Charchar FJ, Wang WY, Lacka B, Padmanabahn S, Clark JS, Anderson NH, Edwards HV, Zukowska-Szczechowska E, Grzeszczak W, Dominiczak AF. Essential hypertension and beta2-adrenergic receptor gene: linkage and association analysis. Hypertension. 2002; 40: 286-291.
8. Tunstall-Pedoe H, for the WHO MONICA Project. The World Health Organization MONICA Project (monitoring trends and determinants in cardiovascular diseases): a major international collaboration. J Clin Epidemiol. 1988; 41: 105-114.
9. Pereira AC, Mota GF, Cunha RS, Herbenhoff FL, Mill JG, Krieger JE. Angiotensinogen 235T allele “dosage” is associated with blood pressure phenotypes. Hypertension. 2003; 41: 25-30.
10. Guidelines Subcommittee. World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. J Hypertens. 1999; 17: 151-183.
11. Large V, Hellstrom L, Reynisdottir S, Lonnqvist F, Eriksson P, Lannfelt L, Arner P. Human beta2 adrenoceptor gene polymorphisms are highly frequent in obesity and associate with altered adipocyte beta2 adrenoceptor function. J Clin Invest. 1997; 100: 3005-3013.
12. Schneider S, Roessli D, Excoffier L. Arlequin ver 2000: a software for population genetics data analysis. Geneva, Switzerland: Genetics and Biometry Laboratory, University of Geneva, Switzerland; 2000.
13. Shork NJ, Krieger JE, Troilliet MR, Franchini KG, Koike G, Krieger EM, Lander ES, Dzau VJ, Jacob HJ, A biometrical genome search in rats reveals the multigenic basis of blood pressure variation. Genome Res. 1995; S: 164-172.
14. Hoffstedt J, Illiadou A, Pedersen NL, Schalling M, Arner P. The effect of the beta(2) adrenoceptor gene Thr164Ile polymorphism on human adipose tissue lipolytic function. Br J Pharmacol. 2001; 133: 708-712.
15. Lin RCY, Ericsson JO, Benjafield AV, Morris BJ. Association of beta2-adrenoceptor Gln27Glu variant with body weight but not hypertension. Am J Hypertens. 2001; 14: 1201-1204.
16. Ishiyama-Shigemoto S, Yamada K, Yuan X, Ichikawa F, Nonaka K. Association of polymorphisms in the beta2-adrenergic receptor gene with obesity, hypertriglyceridaemia, and diabetes mellitus. Diabetologia. 1999; 42: 98-101.
17. Mori Y, Kim-Motoyama H, Ito Y, Katakura T, Yasuda K, Ishiyama-Shigemoto S, Yamada K, Akanuma Y, Ohashi Y, Kimura S, Yazaki Y, Kadowaki T. The Gln27Glu beta2-adrenergic receptor variant is associated with obesity due to subcutaneous fat accumulation in Japanese men. Biochem Biophys Res Commun. 1999; 258: 138-140.
18. Jia H, Sharma P, Hopper R, Dickerson C, Lloyd DD, Brown MJ. β2-Adrenoceptor gene polymorphisms and blood pressure variations in East Anglican Caucasians. J Hypertens. 2000; 18: 687-693.
19. Bray MS, Krushkal J, Li L, Ferrell R, Kardia S, Sing CF, Turner ST, Boerwinkle E. Positional genomic analysis identifies the β2-adrenergic receptor gene as a susceptibility locus for human hypertension. Circulation. 2000; 101: 2877-2882.
20. Kotanko P, Binder A, Tasker J, DeFreitas P, Kamdar S, Clark AJL, Skrabal F, Caulfield M. Essential hypertension in African Caribbeans associates with a variant of the β2-adrenoceptor. Hypertension. 1997; 30: 773-776.
21. Meirhaeghe A, Luan J, Selberg-Franks P, Hennings S, Mitchell J, Halsall D, O’Rahilly S, Wareham NJ. The effect of the Gly16Arg polymorphism of the beta(2)-adrenergic receptor gene on plasma free fatty acid levels is modulated by physical activity. J Clin Endocrinol Metab. 2001; 86: 5881-5887.